Page last updated: 2024-12-06

adimolol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID71227
CHEMBL ID1742448
SCHEMBL ID1254721
MeSH IDM0131905

Synonyms (18)

Synonym
adimolol
3-[3-[(2-hydroxy-3-naphthalen-1-yloxypropyl)amino]-3-methylbutyl]-1h-benzimidazol-2-one
78459-19-5
CHEMBL1742448
(+-)-1-(3-((2-hydroxy-3-(1-naphthyloxy)propyl)amino)-3-methylbutyl)-2-benzimidazolinone
adimolol [inn]
b6cjy5k2st ,
adimololum [latin]
unii-b6cjy5k2st
adimololum
(rs)-2,3-dihydro-1-(3-(2-hydroxy-3-(naphthyloxy)propylamino)-3-methylbutyl)-1h-2-benzimidazolon
adimolol [mart.]
(+/-)-1-(3-((2-hydroxy-3-(1-naphthyloxy)propyl)amino)-3-methylbutyl)-2-benzimidazolinone
SCHEMBL1254721
Q4682859
1,3-dihydro-1-[3-[[2-hydroxy-3-(1-naphthalenyloxy)propyl]amino]-3-methylbutyl]-2h-benzimidazol-2-one
1-(3-((2-hydroxy-3-(1-naphthyloxy)propyl)amino)-3-methylbutyl)-2-benzimidazolinone
DTXSID00868480

Research Excerpts

Overview

Adimolol is a new antihypertensive agent with strong nonselective beta- and moderate alpha-adrenolytic properties.

ExcerptReferenceRelevance
"Adimolol is a new antihypertensive agent with strong nonselective beta- and moderate alpha-adrenolytic properties. "( Blood pressure lowering action and alpha-adrenolytic effect of adimolol in rats.
Hoefke, W; Palluk, R,
)
1.81

Pharmacokinetics

ExcerptReferenceRelevance
"The pharmacokinetic properties of adimolol (MEN 935), a new antihypertensive agents with predominantly beta-receptor blocking and additional alpha-adrenolytic activity were investigated in healthy volunteers."( Pharmacokinetics of adimolol after single and multiple dose administration in healthy volunteers.
Adamus, S; Brantl, V; Justus, H; Lohmann, H; Peil, H; Wiedemann, I, 1985
)
0.87

Dosage Studied

ExcerptRelevanceReference
" Labetalol 400 mg significantly shifted the blood pressure dose-response curve to the right."( Comparative effects of adimolol, labetalol and propranolol on heart rate and blood pressure in man.
Harron, DW; Riddell, JG; Shanks, RG, 1985
)
0.58
" In addition, adimolol significantly reduced receptor number and even by 3 days after dosing Bmax had only returned to half the control value."( Adimolol, a long acting beta-adrenoceptor blocker in man.
Deighton, NM; Elliott, HL; Jones, CR; Meredith, PA; Reid, JL, 1987
)
2.08
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (33.33%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (66.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]